<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marc F Catalano, MD, FACG, FACP, FASGE, AGAF</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vivek Kaul, MD, FACG, FASGE, AGAF</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas G Adler, MD, FACG, AGAF, FASGE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Endoscopic interventions such as pancreatic duct stenting have been increasingly used for treating pancreatic disorders such as pancreatic duct obstruction and pancreatic duct leakage. This topic will review issues related to endoscopic retrograde cholangiopancreatography (ERCP)-guided pancreatic duct stenting including indications for therapeutic stenting, stent placement and removal techniques, and complications.</p><p>The use of pancreatic stents to prevent post-ERCP pancreatitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>.)</p><p>Endoscopic management of walled-off pancreatic fluid collections is discussed separately. (See  <a class="medical medical_review" href="/d/html/5650.html" rel="external">"Endoscopic interventions for walled-off pancreatic fluid collections"</a>.)</p><p>The use of biliary stents for treating malignant pancreaticobiliary obstruction is discussed separately. (See  <a class="medical medical_review" href="/d/html/13925.html" rel="external">"Endoscopic stenting for malignant biliary obstruction"</a>.)</p><p>The use of biliary stents for treating nonmalignant disease is discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Primary sclerosing cholangitis – (See  <a class="medical medical_review" href="/d/html/661.html" rel="external">"Primary sclerosing cholangitis in adults: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Post-surgical biliary complications – (See  <a class="medical medical_review" href="/d/html/4596.html" rel="external">"Liver transplantation in adults: Endoscopic management of biliary adverse events"</a> and  <a class="medical medical_review" href="/d/html/637.html" rel="external">"Endoscopic management of postcholecystectomy biliary complications"</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h1">INDICATIONS</span></p><p class="headingAnchor" id="H2429069717"><span class="h2">Therapeutic stent placement</span></p><p class="headingAnchor" id="H7"><span class="h3">Pancreatic duct obstruction</span><span class="headingEndMark"> — </span>Endoscopic therapy is indicated for patients with abdominal pain due to pancreatic ductal obstruction, most commonly caused by pancreatic duct stricture(s) and/or stone(s) [<a href="#rid1">1</a>]. Of note, endoscopic therapy alone is generally less feasible for stones or strictures in the body of the pancreas and is impossible if the obstruction is in the tail of the pancreas. The endoscopic interventions often involve a pancreatic sphincterotomy, removal of pancreatic stones (if present), and placement of a transpapillary pancreatic duct stent. </p><p>Chronic pancreatitis is often characterized by pain that may be related to increased pressure within the pancreatic ductal system secondary to outflow obstruction of the main pancreatic duct [<a href="#rid2">2</a>]. Pancreatic duct stenting has been associated with improvement in pain among patients with chronic pancreatitis with downstream duct strictures resulting in upstream (ie, closer to the tail of the pancreas) dilation [<a href="#rid3">3,4</a>]. The management of chronic pancreatitis is discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/5647.html" rel="external">"Chronic pancreatitis: Management"</a>.) </p><p>Some patients with pancreatic duct strictures also develop pancreatic duct stone formation upstream from the stricture [<a href="#rid4">4</a>]. For patients with stones that cannot be completely cleared, stent placement assists in drainage of pancreatic juices. Risk factors for incomplete stone removal include &gt;3 stones, stones in the pancreatic tail, stone size ≥10 mm, impacted stone(s), and downstream pancreatic duct stricture [<a href="#rid5">5</a>]. </p><p class="headingAnchor" id="H14"><span class="h3">Pancreatic duct leakage</span><span class="headingEndMark"> — </span>ERCP-guided placement of a transpapillary pancreatic stent is indicated for patients with pancreatic fistulas who are symptomatic or those with persistent or enlarging fluid collections on abdominal imaging despite supportive care. Pancreatic ductal disruptions may arise from acute or chronic pancreatitis, trauma, or surgical injury. Duct disruptions lead to leakage of pancreatic fluid that may result in chronic pancreatic fistula  (<a class="graphic graphic_table graphicRef66011" href="/d/graphic/66011.html" rel="external">table 1</a>). Endoscopic therapy promotes internal drainage of pancreatic secretions, thereby reducing flow through the fistula tract. Findings suggestive of a pancreatic duct disruption include extravasation of contrast during injection of the pancreatic duct during ERCP, pancreatic ascites, pancreatic fistula, or a fluid collection that communicates directly with the main pancreatic duct [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/d/html/5650.html" rel="external">"Endoscopic interventions for walled-off pancreatic fluid collections", section on 'ERCP-guided transpapillary drainage'</a>.)</p><p>The management of walled-off pancreatic fluid collections is discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/5651.html" rel="external">"Approach to walled-off pancreatic fluid collections in adults"</a>.)</p><p class="headingAnchor" id="H435106259"><span class="h3">Other interventions</span><span class="headingEndMark"> — </span>Pancreatic stent placement is used in combination with extracorporeal shock wave lithotripsy (ESWL) for patients without clearance of pancreatic stones after fragmentation by ESWL [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/5658.html" rel="external">"Extracorporeal shock wave lithotripsy for pancreatic stones"</a>.)</p><p class="headingAnchor" id="H3750206638"><span class="h2">Stenting as a preventive strategy</span><span class="headingEndMark"> — </span>Pancreatic duct stent placement has been used to prevent pancreatitis in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>Post ERCP-pancreatitis – The role of pancreatic stenting to prevent post-ERCP pancreatitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/675.html" rel="external">"Management of difficult biliary access during ERCP in adults", section on 'Pancreatic stenting'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent idiopathic acute pancreatitis – Prophylactic pancreatic duct stenting with or without pancreatic sphincterotomy has been reported for patients with recurrent bouts of idiopathic pancreatitis [<a href="#rid8">8</a>]. However, randomized trials are needed to clarify the role of this intervention in such patients. (See  <a class="medical medical_review" href="/d/html/5640.html" rel="external">"Etiology of acute pancreatitis"</a>.)</p><p></p><p class="headingAnchor" id="H4263707728"><span class="h1">CONTRAINDICATIONS</span><span class="headingEndMark"> — </span>ERCP-guided pancreatic duct stenting is typically contraindicated in the following patients:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who cannot tolerate sedation, monitored anesthesia care or general anesthesia (see  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults"</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with an untreated hemostatic disorder who are deemed to be at high risk for bleeding by the advanced endoscopist (see  <a class="medical medical_review" href="/d/html/2553.html" rel="external">"Gastrointestinal endoscopy in patients with disorders of hemostasis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are hemodynamically unstable</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with gastrointestinal (luminal) obstruction may undergo endoscopy, but the examination may be limited to an area proximal to the level of obstruction (see  <a class="medical medical_review" href="/d/html/2676.html" rel="external">"Enteral stents for the palliation of malignant gastroduodenal obstruction"</a>)</p><p></p><p class="headingAnchor" id="H1275979233"><span class="h1">PREPROCEDURE EVALUATION</span><span class="headingEndMark"> — </span>The diagnosis of pancreatic duct obstruction or pancreatic duct leakage is often suspected based on presenting symptoms (eg, abdominal pain, weight loss) and cross-sectional imaging (computed tomography [CT] scan, magnetic resonance imaging [MRI] with magnetic resonance cholangiopancreatography [MRCP]). Thus, most patients will have had imaging, thereby mitigating the need for additional radiographic imaging before ERCP. Review of the radiographic imaging prior to ERCP will help to define the biliary and pancreatic ductal anatomy, exclude pancreas divisum, and identify pancreatic duct stones. (See  <a class="medical medical_review" href="/d/html/5649.html" rel="external">"Chronic pancreatitis: Clinical manifestations and diagnosis in adults"</a>.)</p><p>During a single endoscopic session, endoscopic ultrasound (EUS) is often performed prior to ERCP because EUS may provide additional information such as defining pancreatic stone location (ie, intraductal or parenchymal) and excluding occult tumors and common bile duct stones.</p><p class="headingAnchor" id="H2729635887"><span class="h1">STENT PLACEMENT</span></p><p class="headingAnchor" id="H1965613586"><span class="h2">Patient preparation</span><span class="headingEndMark"> — </span>The preprocedure preparation for patients undergoing ERCP with pancreatic duct stent placement is similar to that described for patients undergoing ERCP for other indications (see  <a class="medical medical_review" href="/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Patient preparation'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Adjusting medications – Most patients do not need to discontinue <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> or nonsteroidal anti-inflammatories when undergoing ERCP. Most patients who undergo ERCP with pancreatic stent placement only (ie, without pancreatic or biliary sphincterotomy) typically do not need to discontinue anticoagulant therapy. The management of antiplatelet and anticoagulant therapy is typically individualized, managed in conjunction with the prescribing specialist, and discussed separately. (See  <a class="medical medical_review" href="/d/html/2632.html" rel="external">"Management of antiplatelet agents in patients undergoing endoscopic procedures"</a> and  <a class="medical medical_review" href="/d/html/2609.html" rel="external">"Management of anticoagulants in patients undergoing endoscopic procedures"</a> and  <a class="medical medical_review" href="/d/html/2553.html" rel="external">"Gastrointestinal endoscopy in patients with disorders of hemostasis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antibiotic prophylaxis – Prophylactic antibiotics are generally not indicated for patients undergoing ERCP with pancreatic duct stent placement in the absence of another indication (eg, biliary obstruction, risk for incomplete drainage, pancreatic fistula)  (<a class="graphic graphic_table graphicRef99536" href="/d/graphic/99536.html" rel="external">table 2</a>). Thus, the use of antibiotic prophylaxis is individualized and based on patient- and procedure-related risk factors for infection, in addition to endoscopist preference. These issues are discussed separately. (See  <a class="medical medical_review" href="/d/html/2545.html" rel="external">"Antibiotic prophylaxis for gastrointestinal endoscopic procedures"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anesthesia – The procedure is typically performed using monitored anesthesia care or general anesthesia. Anesthetic management for endoscopic procedures including preprocedure fasting is discussed separately. (See  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults"</a>.) </p><p></p><p class="headingAnchor" id="H2510173499"><span class="h2">Stents and other equipment</span></p><p class="headingAnchor" id="H2047708770"><span class="h3">Types of stents</span><span class="headingEndMark"> — </span>Pancreatic stents are available in varying lengths, diameters, and designs. Newer stents may be brought to market, and availability varies by geographic area. Features of pancreatic stents include [<a href="#rid9">9,10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Material – Most pancreatic stents are plastic stents composed of polyethylene materials. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Size – Pancreatic stents are available in diameter sizes ranging from 3 to 10 French (Fr) and in lengths ranging from 2 to 15 cm. Larger stents (10 Fr) are rarely used and are reserved for patients with a markedly dilated, obstructed pancreatic duct (ie, duct diameter ≥4 mm) that requires drainage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Design – Pancreatic stents are cylindrical in shape, and various designs are available. Pancreatic stents may be either straight, curved, or single pigtail. Most stents have features that help prevent internal migration (eg, distal flange, pigtail). Some stents have both proximal and distal flaring to help anchor the stent. In addition, some stents have radiopaque markers to improve visibility under fluoroscopy. </p><p></p><p>Some stents in development have features that mitigate the need for endoscopic stent removal (eg, biodegradable stent) [<a href="#rid11">11-13</a>]. Other types of pancreatic stents are being studied such as self-expandable stents (eg, removable, fully covered, metallic stents), but they are not used routinely in clinical practice [<a href="#rid14">14</a>].  </p><p>Stent selection is individualized and informed by the duct length to be traversed, diameter of the duct lumen, indication for stenting (eg, obstruction, leakage), duct morphology (eg, disruption), and endoscopist preference [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H4287279214"><span class="h3">Guidewires</span><span class="headingEndMark"> — </span>Guidewires are used to facilitate stent deployment. Guidewires vary in diameter (eg, 0.018 inch, 0.021 inch, 0.025 inch, and 0.035 inch) and length, and may be hydrophilic, straight, have a "J" tip, or a loop tip. Guidewires are available with various radiopaque markings to aid in visualization and to minimize fluoroscopy time. Some guidewires are Teflon-coated, which provides stability for stent placement and accessory exchanges. "Glidewire" and "Roadrunner" are specialized wires that are used for patients with conditions resulting in difficult cannulation (eg, papillary stenosis). </p><p>It is important to keep in mind that guidewire caliber needs to be compatible with the catheter and stent size (eg, a 0.035 inch guidewire cannot be used to place a 3 Fr pancreatic stent or with a 4 Fr cannulation catheter). </p><p class="headingAnchor" id="H2463220840"><span class="h3">Dilators</span><span class="headingEndMark"> — </span>Two types of dilators are commonly used: balloon dilators and passage dilator catheters. Balloon dilators are inflation devices housed on a catheter, which are used to deliver a specific radial pressure to a stenotic area. They are available in several diameters and lengths. An inflation device is required to pressurize the balloon at a controlled rate.</p><p>Passage dilation catheters are available with a variety of tip sizes (ie, 3 to 11.5 Fr) or as graduated dilating catheters. The size of the tip of the catheter limits the size of the guidewire that can be used with it. </p><p class="headingAnchor" id="H2406325119"><span class="h2">Stent deployment</span><span class="headingEndMark"> — </span>Pancreatic duct stents are usually placed under endoscopic and fluoroscopic guidance. </p><p class="headingAnchor" id="H1159651997"><span class="h3">Pancreatic ductal obstruction</span><span class="headingEndMark"> — </span>The technique for stent placement for patients with ductal obstruction is summarized as follows [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Cannulate the ampulla and pancreatic duct. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Place a guidewire across the location of the stricture and/or stone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Perform pancreatic sphincterotomy and stricture dilation, if needed  (<a class="graphic graphic_diagnosticimage graphicRef59903 graphicRef70294" href="/d/graphic/59903.html" rel="external">image 1A-B</a>). As an example, patients with multiple or large pancreatic stones may require a combination of pancreatic sphincterotomy, stricture dilation, and/or other stone removal methods in addition to stent placement. Pancreatic sphincterotomy is used to facilitate access to the main pancreatic duct and passage of endoscopic accessories used for stricture dilation and stone removal. Patients being treated for a pancreatic leak or duct disruption may not always require a pancreatic sphincterotomy.  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Advance the stent over the guidewire and deploy it. Because of the small diameter of most pancreatic stents (eg, &lt;10 Fr), they are usually deployed with only a guidewire and pushing catheter. To avoid placing the stent completely within the pancreatic duct, we maintain steady (but not increased) pressure on the pushing catheter, and we direct the endoscopy assistant to maintain steady wire traction. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After stent deployment, document the stent position by obtaining endoscopic and fluoroscopic images.</p><p></p><p>Stent indwell time is individualized and is informed by the indication for stenting and symptomatic response. However, most stents typically remain in place for four to eight weeks prior to exchange or removal. (See <a class="local">'Stent removal or replacement'</a> below.)</p><p>Modifications to stent insertion technique can help minimize risks associated with pancreatic stenting [<a href="#rid16">16</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Avoid placing the upstream portion of the stent at or around the genu of the pancreas. Transpapillary stents should either traverse the genu completely or remain entirely distal to the genu. Stents that terminate near the genu may be more likely to cause ductal injury or even perforation due to the sharp angulation at that site [<a href="#rid17">17</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Variations in pancreatic duct anatomy may inform the approach to stent placement. As an example, wire cannulation of the pancreatic duct may be limited in patients with ansa pancreatica, an anatomic variant consisting of a loop connecting the inferior branches of the dorsal and ventral ducts [<a href="#rid18">18</a>].<strong> </strong>For patients with such ductal anatomy, a shorter transpapillary stent (eg, 2 to 3 cm in length) may be chosen because it reduces manipulation of the pancreatic duct at the level of the ansa loop [<a href="#rid19">19</a>].</p><p></p><p>Endoscopic therapy with dilation and stenting for pancreatic duct strictures with or without intraductal stones has been effective in reducing abdominal pain in 65 to 84 percent of patients [<a href="#rid3">3,20,21</a>]. In a study including over 1000 patients with chronic pancreatitis with mean follow-up of five years (range two to 12 years), pancreatic endotherapy for strictures, stones, or both was associated with improvement in pain in 65 percent of patients [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H4063038477"><span class="h3">Pancreatic duct leakage</span><span class="headingEndMark"> — </span>For patients with pancreatic duct leakage, the technique for stent placement is generally similar to placing a transpapillary stent for ductal obstruction. (See <a class="local">'Pancreatic ductal obstruction'</a> above.) </p><p>For patients with pancreatic duct leakage, stents are usually removed after four to six weeks and are not replaced if the ductal disruption has resolved. (See <a class="local">'Stent removal or replacement'</a> below.)</p><p>Bridging the region of the disruption with the stent is often accomplished, while nonbridging transpapillary stent placement also promotes healing by reducing resistance to pancreatic juice flow [<a href="#rid22">22</a>]. In a study of 43 patients with pancreatic duct disruption treated with pancreatic duct stenting, 25 patients (58 percent) had resolution of the disruption [<a href="#rid23">23</a>]. Factors associated with resolved ductal leakage after stenting included bridging of the ductal disruption and longer duration of stenting (ie, six weeks).</p><p class="headingAnchor" id="H1767421135"><span class="h2">Post-procedure care</span><span class="headingEndMark"> — </span>Routine post-procedure care following ERCP is discussed separately. (See  <a class="medical medical_review" href="/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"</a>.)</p><p class="headingAnchor" id="H2913420552"><span class="h1">STENT REMOVAL OR REPLACEMENT</span></p><p class="headingAnchor" id="H3117556300"><span class="h2">Timing</span><span class="headingEndMark"> — </span>The duration of stenting is informed by the indications for stenting and the clinical response to stenting (eg, symptomatic improvement). As an example, for patients with pancreatic duct leakage, stents are usually removed after four to six weeks and are not replaced if the ductal disruption has resolved. For patients who require stent replacement (also referred to as stent exchange), stents are generally replaced every four to eight weeks until symptoms are relieved. However, there is no clear consensus on the optimal time interval between stent exchanges, and clinical practice is also guided by endoscopist preference. (See <a class="local">'Stent deployment'</a> above.)</p><p>Factors contributing to the uncertainty regarding timing of stent removal and replacement are the low reported rates of symptomatic stent occlusion and the risk, burden, and cost associated with therapeutic ERCP. In a study examining outcomes after 146 pancreatic duct stent placements in 115 patients, six percent of patients with occluded stents required hospitalization for pancreatitis or increased pain [<a href="#rid24">24</a>]. The low rates of symptomatic stent occlusion may be related to the observation that occluded stents may function as a "wick" around which pancreatic juices continue to drain [<a href="#rid25">25</a>]. </p><p class="headingAnchor" id="H670762912"><span class="h2">Technique</span><span class="headingEndMark"> — </span>The technique for removing a stent from the pancreatic duct is summarized as follows  (<a class="graphic graphic_picture graphicRef133262" href="/d/graphic/133262.html" rel="external">picture 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Use a duodenoscope to visualize the ampulla and the intraluminal portion of the stent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Grasp the stent close to the tip, distal to the flaps (or flanges). Avoid excessive tightening of the snare around the stent to prevent stent fracture. Alternatively, a biopsy forceps may be used to grasp the stent for removal. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extract the stent smoothly from the duct by grasping the catheter at the accessory channel and applying traction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After the stent is removed from the pancreatic duct, pull the snare and stent through the duodenoscope. The removed stent is inspected to confirm that it is intact and without any fracture.</p><p></p><p>Patients with conditions that require multiple stent exchanges (eg, stricture related to chronic pancreatitis) may benefit from using varying stent lengths at subsequent exchanges, since most stent-induced ductal changes occur at the upstream end of the stent within the pancreatic duct [<a href="#rid4">4</a>]. Whenever possible, shorter stents are preferred over longer stents to limit the area of the pancreatic duct that comes in contact with the foreign stent material, provided that the ductal obstruction (or disruption) has been traversed. (See <a class="local">'Stent-related morphologic changes'</a> below.)</p><p class="headingAnchor" id="H4043763986"><span class="h1">ADVERSE EVENTS</span><span class="headingEndMark"> — </span>Adverse events associated with ERCP-guided pancreatic duct stent placement may be related to the ERCP or to stent placement.</p><p class="headingAnchor" id="H3242507651"><span class="h2">ERCP-related</span><span class="headingEndMark"> — </span>Complications associated with ERCP may be due to the endoscopy itself (eg, acute pancreatitis, perforation) or due to anesthesia (eg, hypotension). These complications are discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Adverse events'</a> and  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults", section on 'Complications'</a>.)</p><p class="headingAnchor" id="H4250512949"><span class="h2">Stent-related</span><span class="headingEndMark"> — </span>Pancreatic duct stent placement has been associated with a range of potential complications. Some complications occur during or within several days of ERCP (ie, acute complications), while other complications are delayed [<a href="#rid19">19,26-29</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute complications include abdominal pain, ductal rupture related to catheter/balloon dilation, gastrointestinal bleeding, intraprocedural inward stent migration, and post-ERCP pancreatitis [<a href="#rid30">30</a>]. Prevention and management of post-ERCP pancreatitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nonacute or delayed complications include stent malfunction (migration, occlusion), stent-related perforation, pancreatic ductal injury, and pancreatic stricture.</p><p></p><p class="headingAnchor" id="H130604459"><span class="h3">Stent-related morphologic changes</span><span class="headingEndMark"> — </span>Pancreatic stents may induce morphologic changes that resemble chronic pancreatitis:</p><p class="bulletIndent1"><span class="glyph">●</span>Prevalence – The reported rates of stent-induced changes (eg, pancreatic strictures, ductal irregularities) have ranged from 18 to 80 percent [<a href="#rid31">31-35</a>]. Stent diameter size has been linked to risk of ductal changes [<a href="#rid31">31,35</a>]. In a study including 2283 patients who underwent ERCP and pancreatic stent placement, smaller diameter stents (3 to 4 Fr) were associated with lower rates of ductal changes compared with larger stents (5 to 6 Fr [24 versus 80 percent]) [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Location – The morphologic changes induced by pancreatic stenting may affect the pancreatic parenchyma (eg, inflammatory response associated with the upstream end of the stent) and/or the pancreatic duct (eg, dilation of side branches, narrowing, and ductal irregularities)  (<a class="graphic graphic_diagnosticimage graphicRef62772 graphicRef63364" href="/d/graphic/62772.html" rel="external">image 2A-B</a>) [<a href="#rid31">31,36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detection – During ERCP that is performed to remove a therapeutic pancreatic stent, the endoscopist may perform a pancreatogram to confirm resolution of the ductal pathology and to evaluate for morphologic changes. (See <a class="local">'Therapeutic stent placement'</a> above.)</p><p></p><p class="bulletIndent1">Stent-related ductal changes may also be detected on magnetic resonance cholangiopancreatography (MRCP).<strong> </strong></p><p></p><p>For patients with stent-induced changes such as ductal stricture, additional endoscopic therapy such as stricture dilation and stenting may be performed.<strong> </strong></p><p>Issues related to morphologic changes in a previously normal pancreas in the setting of prophylactic stenting to prevent ERCP-related pancreatitis are discussed separately. (See  <a class="medical medical_review" href="/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>.)</p><p class="headingAnchor" id="H22"><span class="h3">Stent occlusion</span><span class="headingEndMark"> — </span>Most pancreatic duct stents occlude within 8 to 12 weeks after placement [<a href="#rid24">24,25,37,38</a>]. In a study including 68 patients with pancreatic duct stents, 42 patients (62 percent) had complete stent occlusion at the time of stent removal and the median time to occlusion was 35 days (95% CI, 30 to 40 days) [<a href="#rid39">39</a>]. Stents with &gt;3 large side holes were less likely to be occluded at the time of stent removal (hazard ratio [HR] 0.46, 95% CI 0.23-0.93).</p><p>Serious complications after stent blockage are uncommon, possibly due to drainage of pancreatic juices alongside the occluded stent such that the stent acts as a wick [<a href="#rid25">25</a>]. However, some patients develop abdominal pain or acute pancreatitis in the setting of stent occlusion [<a href="#rid27">27,33,37,40</a>]. As a result, most advanced endoscopists perform stent exchanges electively before occlusion is expected to occur. (See <a class="local">'Stent removal or replacement'</a> above.)</p><p>Occluded pancreatic stents can be treated endoscopically by removing the occluded stent and replacing it with a new plastic stent. </p><p>The adherence of proteins to the inner surface of the stent seems to play a central role in stent occlusion [<a href="#rid34">34</a>]. The occluding material (biofilm) consists of a protein matrix laden with <a class="drug drug_general" data-topicid="9185" href="/d/drug information/9185.html" rel="external">calcium carbonate</a> crystals, mucopolysaccharides, and plant material [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H23"><span class="h3">Stent migration</span><span class="headingEndMark"> — </span>Pancreatic duct stents may migrate in one of two directions:</p><p class="bulletIndent1"><span class="glyph">●</span>Downstream stent migration (ie, outside the duct) rarely results in symptoms such as worsening abdominal pain because the stent passes into the duodenum and is then excreted [<a href="#rid41">41</a>]. In one report including 589 stent placements, the rate of downstream stent migration was 8 percent [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Upstream (or inward) stent migration (ie, into the duct) may lead to further complications because of stent-induced ductal damage and technical challenges associated with stent retrieval (small pancreatic duct diameter, bended duct course, presence of stricture) [<a href="#rid42">42,43</a>]. In one report including 589 stent placements, upstream migration developed in 5 percent of patients [<a href="#rid40">40</a>]. </p><p></p><p class="bulletIndent1">However, most migrated pancreatic stents can be retrieved endoscopically  (<a class="graphic graphic_diagnosticimage graphicRef58513" href="/d/graphic/58513.html" rel="external">image 3</a>) [<a href="#rid42">42,44</a>]. Surgical extraction is infrequently needed but has been performed for patients with upstream migrated pancreatic stents in whom ERCP-guided retrieval attempts have failed [<a href="#rid45">45,46</a>]. Pancreatoscopy may facilitate extraction of migrated pancreatic stents that cannot be removed using retrieval techniques such as balloon catheter or grasping device methods [<a href="#rid47">47,48</a>]. (See  <a class="medical medical_review" href="/d/html/633.html" rel="external">"Cholangioscopy and pancreatoscopy"</a>.)</p><p></p><p class="bulletIndent1">The risk of upstream stent migration can be decreased by initial positioning the stent such that it does not extend beyond the genu of the pancreas. In addition, modifications of stent design have been studied to reduce the risk of internal migration. One possible approach is eliminating internal stent flaring, which in one report, decreased risk of upstream migration but increased the risk of downstream migration [<a href="#rid35">35,40,49,50</a>]. </p><p></p><p class="headingAnchor" id="H3501675710"><span class="h3">Other complications</span><span class="headingEndMark"> — </span>Other complications related to pancreatic duct stenting include ductal damage from the dilating catheter, cholangitis, and acute pancreatitis. While acute pancreatitis is a known complication associated with ERCP, data have suggested that unsuccessful pancreatic stent insertion was a risk factor for post-ERCP pancreatitis. In a study including 225 therapeutic ERCPs, failed stent insertion was associated with higher rates of acute pancreatitis compared with successful stent placement (67 versus 14 percent) [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>.) </p><p class="headingAnchor" id="H2866469595"><span class="h2">Evaluating for a suspected complication</span><span class="headingEndMark"> — </span>For patients who had ERCP with pancreatic stent placement and then developed symptoms such as new or worsening abdominal pain, our initial evaluation for complications typically consists of laboratory testing (ie, liver biochemical tests, amylase) and abdominal imaging (ie, plain film of the abdomen or computed tomography scan if a walled-off pancreatic fluid collection is suspected). (See  <a class="medical medical_review" href="/d/html/5651.html" rel="external">"Approach to walled-off pancreatic fluid collections in adults", section on 'Clinical features'</a>.) </p><p class="headingAnchor" id="H163987875"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118263.html" rel="external">"Society guideline links: Endoscopic retrograde cholangiopancreatography (ERCP)"</a>.)</p><p class="headingAnchor" id="H30"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for therapeutic stent placement</strong> – Endoscopic retrograde cholangiopancreatography (ERCP)-guided pancreatic duct stenting has been increasingly used for treating pancreatic disorders such as pancreatic duct obstruction (often related to pancreatic stricture and/or stones) and pancreatic duct leakage. (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preprocedure evaluation -</strong> Most patients will have had imaging prior to ERCP with pancreatic duct stent placement, thereby mitigating the need for additional imaging prior to the procedure. The diagnosis of pancreatic duct obstruction or pancreatic duct leakage is often suspected based on presenting symptoms (eg, abdominal pain, weight loss) and cross-sectional imaging (eg, computed tomography [CT] scan, magnetic resonance imaging [MRI] with magnetic resonance cholangiopancreatography [MRCP]). (See <a class="local">'Preprocedure evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient preparation -</strong> Antibiotic prophylaxis prior to ERCP-guided pancreatic stent placement is generally not indicated in the absence of another indication (eg, biliary obstruction, risk for incomplete drainage)  (<a class="graphic graphic_table graphicRef99536" href="/d/graphic/99536.html" rel="external">table 2</a>). Thus, the use of antibiotic prophylaxis is individualized and based on patient- and procedure-related risk factors for infection in addition to endoscopist preference. (See <a class="local">'Patient preparation'</a> above and  <a class="medical medical_review" href="/d/html/2545.html" rel="external">"Antibiotic prophylaxis for gastrointestinal endoscopic procedures"</a>.)  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Types of pancreatic stents -</strong> Pancreatic stents are available in varying lengths, diameters, and designs and are primarily composed of polyethylene materials. Pancreatic stents are cylindrical in shape, and most stents have features that help prevent internal migration (eg, distal flange, pigtail). (See <a class="local">'Types of stents'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Duration of pancreatic stent placement -</strong> The duration of stent placement is informed by the indications for and clinical response to stenting (eg, symptomatic improvement) (see <a class="local">'Stent removal or replacement'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with pancreatic duct leakage, stents are usually removed after four to six weeks and are not replaced if the duct disruption has resolved. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with pancreatic duct obstruction, stents are generally replaced every four to eight weeks with the endpoint being resolution of symptoms. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adverse events -</strong> Adverse events reported with ERCP-guided pancreatic duct stent placement may be related to the ERCP or to stent placement:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complications associated with ERCP may be due to the endoscopy itself (eg, acute pancreatitis, perforation) or due to anesthesia (eg, hypotension). (See <a class="local">'ERCP-related'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complications related to pancreatic stenting include stent dysfunction (eg, occlusion, migration) and stent-related morphologic changes involving the pancreatic duct (eg, stricture, irregularities) or parenchyma (eg, inflammatory change). (See <a class="local">'Stent-related'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nabi Z, Lakhtakia S. Endoscopic management of chronic pancreatitis. Dig Endosc 2021; 33:1059.</a></li><li><a class="nounderline abstract_t">Ito K, Okano N, Hara S, et al. 10 Fr S-Type Plastic Pancreatic Stents in Chronic Pancreatitis Are Effective for the Treatment of Pancreatic Duct Strictures and Pancreatic Stones. Gastroenterol Res Pract 2018; 2018:6056379.</a></li><li><a class="nounderline abstract_t">Rösch T, Daniel S, Scholz M, et al. Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy 2002; 34:765.</a></li><li><a class="nounderline abstract_t">Khara HS, Kothari TH, Johal AS, et al. Heads or tails: confusion about "proximal" and "distal" terminology for pancreaticobiliary anatomy. Endosc Int Open 2018; 6:E801.</a></li><li><a class="nounderline abstract_t">Sherman S, Lehman GA, Hawes RH, et al. Pancreatic ductal stones: frequency of successful endoscopic removal and improvement in symptoms. Gastrointest Endosc 1991; 37:511.</a></li><li><a class="nounderline abstract_t">Devière J, Bueso H, Baize M, et al. Complete disruption of the main pancreatic duct: endoscopic management. Gastrointest Endosc 1995; 42:445.</a></li><li><a class="nounderline abstract_t">Dumonceau JM, Delhaye M, Tringali A, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated August 2018. Endoscopy 2019; 51:179.</a></li><li><a class="nounderline abstract_t">Jacob L, Geenen JE, Catalano MF, Geenen DJ. Prevention of pancreatitis in patients with idiopathic recurrent pancreatitis: a prospective nonblinded randomized study using endoscopic stents. Endoscopy 2001; 33:559.</a></li><li><a class="nounderline abstract_t">Somogyi L, Chuttani R, Croffie J, et al. Biliary and pancreatic stents. Gastrointest Endosc 2006; 63:910.</a></li><li><a class="nounderline abstract_t">ASGE Technology Assessment Committee, Pfau PR, Pleskow DK, et al. Pancreatic and biliary stents. Gastrointest Endosc 2013; 77:319.</a></li><li><a class="nounderline abstract_t">Anderloni A, Fugazza A, Maroni L, et al. New biliary and pancreatic biodegradable stent placement: a single-center, prospective, pilot study (with video). Gastrointest Endosc 2020; 92:405.</a></li><li><a class="nounderline abstract_t">Cahen DL, van der Merwe SW, Laleman W, et al. A biodegradable non-covered self-expandable stent to treat pancreatic duct strictures in chronic pancreatitis: a proof of principle. Gastrointest Endosc 2018; 87:486.</a></li><li><a class="nounderline abstract_t">Maieron A, Erhart L, Pramhofer P, et al. Biodegradable biliopancreatic stents could help conserve health care resources during the COVID-19 pandemic: An observational multicenter study. Dig Liver Dis 2023; 55:310.</a></li><li><a class="nounderline abstract_t">Tringali A, Vadalà di Prampero SF, Landi R, et al. Fully covered self-expandable metal stents to dilate persistent pancreatic strictures in chronic pancreatitis: long-term follow-up from a prospective study. Gastrointest Endosc 2018; 88:939.</a></li><li><a class="nounderline abstract_t">Testoni PA. Endoscopic stenting in benign pancreatic diseases. JOP 2007; 8:141.</a></li><li><a class="nounderline abstract_t">Elta GH. Temporary prophylactic pancreatic stents: which patients need them? Gastrointest Endosc 2008; 67:262.</a></li><li><a class="nounderline abstract_t">Freeman ML. Current Status of Endoscopic Stenting of the Pancreatic Duct as Prophylaxis Against Post-ERCP Pancreatitis. Gastroenterol Hepatol (N Y) 2012; 8:618.</a></li><li><a class="nounderline abstract_t">Guerroum H, Rami A, Kassimi M, et al. Ansa pancreatica: a rare cause of acute recurrent episode in chronic pancreatitis. BJR Case Rep 2021; 7:20200044.</a></li><li><a class="nounderline abstract_t">Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004; 59:8.</a></li><li><a class="nounderline abstract_t">Costamagna G, Bulajic M, Tringali A, et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy 2006; 38:254.</a></li><li><a class="nounderline abstract_t">Seza K, Yamaguchi T, Ishihara T, et al. A long-term controlled trial of endoscopic pancreatic stenting for treatment of main pancreatic duct stricture in chronic pancreatitis. Hepatogastroenterology 2011; 58:2128.</a></li><li><a class="nounderline abstract_t">ASGE Standards of Practice Committee, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in benign pancreatic disease. Gastrointest Endosc 2015; 82:203.</a></li><li><a class="nounderline abstract_t">Telford JJ, Farrell JJ, Saltzman JR, et al. Pancreatic stent placement for duct disruption. Gastrointest Endosc 2002; 56:18.</a></li><li><a class="nounderline abstract_t">Ikenberry SO, Sherman S, Hawes RH, et al. The occlusion rate of pancreatic stents. Gastrointest Endosc 1994; 40:611.</a></li><li><a class="nounderline abstract_t">Farnbacher MJ, Berner L, Raithel M, et al. Cleaning of occluded pancreatic duct endoprostheses: a new indication for extracorporeal shock wave lithotripsy? Gastrointest Endosc 2011; 74:527.</a></li><li><a class="nounderline abstract_t">Ashby K, Lo SK. The role of pancreatic stenting in obstructive ductal disorders other than pancreas divisum. Gastrointest Endosc 1995; 42:306.</a></li><li><a class="nounderline abstract_t">Smits ME, Badiga SM, Rauws EA, et al. Long-term results of pancreatic stents in chronic pancreatitis. Gastrointest Endosc 1995; 42:461.</a></li><li><a class="nounderline abstract_t">Ponchon T, Bory RM, Hedelius F, et al. Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol. Gastrointest Endosc 1995; 42:452.</a></li><li><a class="nounderline abstract_t">Cremer M, Devière J, Delhaye M, et al. Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy 1991; 23:171.</a></li><li><a class="nounderline abstract_t">Geenen JE, Rolny P. Endoscopic therapy of acute and chronic pancreatitis. Gastrointest Endosc 1991; 37:377.</a></li><li><a class="nounderline abstract_t">Lawrence C, Cotton PB, Romagnuolo J, et al. Small prophylactic pancreatic duct stents: an assessment of spontaneous passage and stent-induced ductal abnormalities. Endoscopy 2007; 39:1082.</a></li><li><a class="nounderline abstract_t">Kozarek RA. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990; 36:93.</a></li><li><a class="nounderline abstract_t">Morgan DE, Smith JK, Hawkins K, Wilcox CM. Endoscopic stent therapy in advanced chronic pancreatitis: relationships between ductal changes, clinical response, and stent patency. Am J Gastroenterol 2003; 98:821.</a></li><li><a class="nounderline abstract_t">Smith MT, Sherman S, Ikenberry SO, et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 1996; 44:268.</a></li><li><a class="nounderline abstract_t">Rashdan A, Fogel EL, McHenry L Jr, et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004; 2:322.</a></li><li><a class="nounderline abstract_t">Bakman YG, Safdar K, Freeman ML. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy 2009; 41:1095.</a></li><li><a class="nounderline abstract_t">Farnbacher MJ, Radespiel-Tröger M, König MD, et al. Pancreatic endoprostheses in chronic pancreatitis: criteria to predict stent occlusion. Gastrointest Endosc 2006; 63:60.</a></li><li><a class="nounderline abstract_t">Farnbacher MJ, Voll RE, Faissner R, et al. Composition of clogging material in pancreatic endoprostheses. Gastrointest Endosc 2005; 61:862.</a></li><li><a class="nounderline abstract_t">Buscaglia JM, DiMaio CJ, Pollack MJ, et al. Are large side holes associated with reduced rates of pancreatic stent occlusion? Results of a prospective study. JOP 2009; 10:496.</a></li><li><a class="nounderline abstract_t">Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc 1992; 38:341.</a></li><li><a class="nounderline abstract_t">Matsumoto K, Katanuma A, Maguchi H. Endoscopic removal technique of migrated pancreatic plastic stents. J Hepatobiliary Pancreat Sci 2014; 21:E34.</a></li><li><a class="nounderline abstract_t">Rana SS, Sharma R, Gupta R. Endoscopic retrieval of two proximally migrated plastic pancreatic duct stents. JGH Open 2020; 4:97.</a></li><li><a class="nounderline abstract_t">Lu Y, Jin Z, Wu JC, et al. Endoscopic retrieval technique of proximally migrated pancreatic stents: a retrospective study in a tertiary centre. Gastroenterol Res Pract 2015; 2015:485980.</a></li><li><a class="nounderline abstract_t">Lahoti S, Catalano MF, Geenen JE, Schmalz MJ. Endoscopic retrieval of proximally migrated biliary and pancreatic stents: experience of a large referral center. Gastrointest Endosc 1998; 47:486.</a></li><li><a class="nounderline abstract_t">Price LH, Brandabur JJ, Kozarek RA, et al. Good stents gone bad: endoscopic treatment of proximally migrated pancreatic duct stents. Gastrointest Endosc 2009; 70:174.</a></li><li><a class="nounderline abstract_t">Lucas DJ, Glaser JJ, Pearl JP. Laparoscopic distal pancreatectomy for retrieval of a proximally migrated pancreatic stent. JSLS 2012; 16:169.</a></li><li><a class="nounderline abstract_t">Kantsevoy SV, Frolova EA, Thuluvath PJ. Successful removal of the proximally migrated pancreatic winged stent by using the SpyGlass visualization system. Gastrointest Endosc 2010; 72:454.</a></li><li><a class="nounderline abstract_t">Rahimi A, Ejtehadi F. SpyGlass Pancreatoscopy and Successful Retrieval of a Proximally Migrated Pancreatic Stent; Unusual Case and Technical Tips. Middle East J Dig Dis 2016; 8:232.</a></li><li><a class="nounderline abstract_t">Johanson JF, Schmalz MJ, Geenen JE. Simple modification of a pancreatic duct stent to prevent proximal migration. Gastrointest Endosc 1993; 39:62.</a></li><li><a class="nounderline abstract_t">Ishihara T, Yamaguchi T, Seza K, et al. Efficacy of s-type stents for the treatment of the main pancreatic duct stricture in patients with chronic pancreatitis. Scand J Gastroenterol 2006; 41:744.</a></li></ol></div><div id="topicVersionRevision">Topic 2658 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33687105" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Endoscopic management of chronic pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30498511" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 10 Fr S-Type Plastic Pancreatic Stents in Chronic Pancreatitis Are Effective for the Treatment of Pancreatic Duct Strictures and Pancreatic Stones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12244496" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29977997" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Heads or tails: confusion about "proximal" and "distal" terminology for pancreaticobiliary anatomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1936826" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pancreatic ductal stones: frequency of successful endoscopic removal and improvement in symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8566636" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Complete disruption of the main pancreatic duct: endoscopic management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30654394" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated August 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11473324" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prevention of pancreatitis in patients with idiopathic recurrent pancreatitis: a prospective nonblinded randomized study using endoscopic stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16733103" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Biliary and pancreatic stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23410693" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pancreatic and biliary stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32145287" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : New biliary and pancreatic biodegradable stent placement: a single-center, prospective, pilot study (with video).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28843580" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A biodegradable non-covered self-expandable stent to treat pancreatic duct strictures in chronic pancreatitis: a proof of principle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36653266" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Biodegradable biliopancreatic stents could help conserve health care resources during the COVID-19 pandemic: An observational multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30142349" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Fully covered self-expandable metal stents to dilate persistent pancreatic strictures in chronic pancreatitis: long-term follow-up from a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17228146" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Endoscopic stenting in benign pancreatic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18226688" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Temporary prophylactic pancreatic stents: which patients need them?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23983649" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Current Status of Endoscopic Stenting of the Pancreatic Duct as Prophylaxis Against Post-ERCP Pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33614111" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ansa pancreatica: a rare cause of acute recurrent episode in chronic pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14722540" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16528652" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22234084" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A long-term controlled trial of endoscopic pancreatic stenting for treatment of main pancreatic duct stricture in chronic pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26077456" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The role of endoscopy in benign pancreatic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12085030" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pancreatic stent placement for duct disruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7988829" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The occlusion rate of pancreatic stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21704991" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Cleaning of occluded pancreatic duct endoprostheses: a new indication for extracorporeal shock wave lithotripsy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8536897" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The role of pancreatic stenting in obstructive ductal disorders other than pancreas divisum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8566639" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Long-term results of pancreatic stents in chronic pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8566637" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1860448" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2070994" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Endoscopic therapy of acute and chronic pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17886200" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Small prophylactic pancreatic duct stents: an assessment of spontaneous passage and stent-induced ductal abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2335298" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12738462" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Endoscopic stent therapy in advanced chronic pancreatitis: relationships between ductal changes, clinical response, and stent patency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8885345" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15067627" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19904701" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16377317" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Pancreatic endoprostheses in chronic pancreatitis: criteria to predict stent occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15933688" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Composition of clogging material in pancreatic endoprostheses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19734624" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Are large side holes associated with reduced rates of pancreatic stent occlusion? Results of a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1607087" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Incidence and risk factors for biliary and pancreatic stent migration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24535753" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Endoscopic removal technique of migrated pancreatic plastic stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32055705" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Endoscopic retrieval of two proximally migrated plastic pancreatic duct stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25918523" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Endoscopic retrieval technique of proximally migrated pancreatic stents: a retrospective study in a tertiary centre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9647373" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Endoscopic retrieval of proximally migrated biliary and pancreatic stents: experience of a large referral center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559842" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Good stents gone bad: endoscopic treatment of proximally migrated pancreatic duct stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22906350" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Laparoscopic distal pancreatectomy for retrieval of a proximally migrated pancreatic stent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20227689" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Successful removal of the proximally migrated pancreatic winged stent by using the SpyGlass visualization system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27698974" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : SpyGlass Pancreatoscopy and Successful Retrieval of a Proximally Migrated Pancreatic Stent; Unusual Case and Technical Tips.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8454148" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Simple modification of a pancreatic duct stent to prevent proximal migration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16716976" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Efficacy of s-type stents for the treatment of the main pancreatic duct stricture in patients with chronic pancreatitis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
